Loading stock…

Celltrion, Inc. (A068270) Stock Verdict & Ratings | Investment Bastion

02Growth

Is it actually growing, and how fast?

A068270Celltrion

Revenue FY25$2.9B

GROWTH RATING↗

AVERAGE57 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+17%8

Revenue, next 1Y+44%10

Revenue, next 3Y, CAGR-21%1

Revenue, next 5Y, CAGR+16%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+56%9

EPS growth, FY27E+13%7

EPS growth, FY28E+16%8

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 17%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Revenue is set to shrink 21%/yr over the next 3 years, ahead of most of the market.7/10

The runway holds up: revenue is set to grow 16%/yr over five years.9/10

Earnings are set to grow faster than sales (EPS about 16%/yr vs revenue -21%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 57% of companies worldwide.

WEAKNESSES

Revenue grew 17%/yr over the last 3 years, but it is set to shrink 21%/yr from here.

BOTTOM LINE

Elite Compounder

A middle-of-the-pack grower heading into decline. The one thing to watch: revenue is forecast to shrink.

03Price Momentum

Is the market behind it right now?

A068270Celltrion

Total return Current102%

Price return Current98.9%

MOMENTUM RATING↗

AVERAGE64 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+2%9

3-month return+5%8

YTD return+8%6

MID & LONG-TERM▾SCORE

% of 52-week high77%5

1-year return+12%6

3-year return+58%6

5-year return+3%4

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+2%) and over three months (+5%).

WATCH

Average long-term results. Multi-year returns are middling (+58% over three years and +2.9% over five), roughly average for the market.

It's up 12% over the past year, but 23% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level so far this year (+8%).

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Celltrion. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Loading charts…

02Growth

Is it actually growing, and how fast?

A068270Celltrion

Revenue FY25$2.9B

GROWTH RATING↗

AVERAGE57 / 100

REVENUE GROWTH▾SCORE

Revenue, last 3Y, CAGR+17%8

Revenue, next 1Y+44%10

Revenue, next 3Y, CAGR-21%1

Revenue, next 5Y, CAGR+16%9

EARNINGS FORECAST▾SCORE

EPS growth, FY26E+56%9

EPS growth, FY27E+13%7

EPS growth, FY28E+16%8

GROWTH ASSESSMENT

STRENGTHS

Revenue grew 17%/yr over the last 3 years, ahead of 70% of companies worldwide.8/10

Revenue is set to shrink 21%/yr over the next 3 years, ahead of most of the market.7/10

The runway holds up: revenue is set to grow 16%/yr over five years.9/10

Earnings are set to grow faster than sales (EPS about 16%/yr vs revenue -21%/yr), so margins should widen.

WATCH

A mid-pack grower, ahead of 57% of companies worldwide.

WEAKNESSES

Revenue grew 17%/yr over the last 3 years, but it is set to shrink 21%/yr from here.

BOTTOM LINE

Elite Compounder

A middle-of-the-pack grower heading into decline. The one thing to watch: revenue is forecast to shrink.

03Price Momentum

Is the market behind it right now?

A068270Celltrion

Total return Current102%

Price return Current98.9%

MOMENTUM RATING↗

AVERAGE64 / 100

SHORT-TERM RETURNS▾SCORE

1-month return+2%9

3-month return+5%8

YTD return+8%6

MID & LONG-TERM▾SCORE

% of 52-week high77%5

1-year return+12%6

3-year return+58%6

5-year return+3%4

MOMENTUM ASSESSMENT

STRENGTHS

Strong recent results. The stock is outperforming over the past month (+2%) and over three months (+5%).

WATCH

Average long-term results. Multi-year returns are middling (+58% over three years and +2.9% over five), roughly average for the market.

It's up 12% over the past year, but 23% below its 52-week high. That is a touch ahead of the market.

Returns sit at the market level so far this year (+8%).

WEAKNESSES

None flagged.

BOTTOM LINE

Fresh Momentum

Short-term returns are strong but the long track record is thin. Momentum is building — confirmation from longer horizons would strengthen the case.

04Value

Are you paying a fair price for it?

Stop guessing on Celltrion. Get the full investment case.

Premium

$20.75/month

Billed annually at $249/year $348

✓
Stock VerdictValuation and investment strategy for 4,000+ stocks. Days of hedge fund analyst research, done in 2 minutes.
✓
RadarFind your next investment idea: top-ranked stocks across all 9 Bastion strategies.
✓
Portfolio ManagerCheck if Bastion algorithms added the stock you care about to their portfolios.

Secure via Stripe

Trusted by 1,000+ investors in our community

Celltrion, Inc.

01Key Ratings

02Growth

03Price Momentum

04Value

Stop guessing on Celltrion. Get the full investment case.

Premium

02Growth

03Price Momentum

04Value

Stop guessing on Celltrion. Get the full investment case.

Premium